IDO1 and inflammatory bowel disease: Our finding that IDO1 is upregulated in both colonic IBD samples and in our treated HIOs (Figure 6A,B) shows the utility of our model for recapitulating in vivo disease processes, given that IDO1 is known to be upregulated in IBD and shown to be highly expressed in inflamed colonic lesions of Crohn’s disease patients [21].